Inside the Stemirna Therapeutics mRNA Covid-19 vaccine factory in Shanghai | South China Morning Post

Stemirna Therapeutics has built a Covid-19 vaccine manufacturing plant in the Chinese city of Shanghai. The company said the facility is capable of producing 200 million doses of its in-house mRNA Covid-19 vaccine annually. The vaccine is currently undergoing clinical trials before the company can start mass product…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.